KRBP – kiromic biopharma, inc. (US:NASDAQ)
Stock Stats
News
Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients [Yahoo! Finance]
Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial [Yahoo! Finance]
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial [Yahoo! Finance]
Form 10-Q Kiromic Biopharma, Inc. For: Mar 31
Form 3 Kiromic Biopharma, Inc. For: May 03 Filed by: Mirandola Leonardo
Form SC 13D/A Kiromic Biopharma, Inc. Filed by: BERSANI PIETRO
Form 4 Kiromic Biopharma, Inc. For: May 03 Filed by: Hungerford Brian
Form PRE 14A Kiromic Biopharma, Inc. For: Jun 26
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.